In situ tissue engineering eliminates cell harvesting surgeries and reduces manufacturing costs substantially. Bypassing cell seeding and cell culture steps improve clinical translatability. This approach was proven by our previous study demonstrating that a bilayer cell-free vascular graft composed of an elastomeric poly(glycerol sebacate) (PGS) tubular core and a tough polycaprolactone (PCL) sheath undergoes constructive host remodeling into neo-arteries in rat abdominal aorta. In the clinical setting, elderly human patients will have lower regenerative capability than young healthy animals used in this and most other biomedical research. Accumulating evidences support that aging is a major risk factor of chronic vascular diseases, and is associated with impaired neovascularization and reduced functionality and mobility of progenitor cells. Thus, we anticipate that arterial regeneration via in situ approach will be more challenging in human patients. To narrow the gap of technology translation to the clinics, this project will: 1, use 18-month-old rats to better predict host remodeling in human patients, and 2, evaluate the effectiveness of using stromal cell-derived factor (SDF)-1? released from the vascular grafts to recruit progenitor cells to compensate for the reduced motility of progenitor cells in older individuals. The objective of this supplement research is to engineer cell-free vascular grafts that can enhance host progenitor cell recruitment in situ and evaluate their transformation into artery-like tissues in aged animals. SDF-1? is a potent chemoattractant for inducing progenitor cell engraftment. It will be released from a coacervate (a form of emulsion) delivery system in a sustained manner. Our preliminary results show that coacervate maintains bioactivity of SDF-1?, supports its long-term sustained release, and enhances migration and recruitment of human progenitor cells in vitro. We hypothesize that active cell recruitment will promote constructive host remodeling in situ, leading to rapid transformation to a neo-artery. The cost of large animals is not justified at this early phase of research, however aged rats will be used to best mirror human patient population. To test our hypothesis, we will accelerate host cell recruitment and endothelialization by controlled release of SDF-1?. We will use both male and female 18 month-old rats to reflect 50-to-65 year old human patients and implant both bare (control) and SDF-1? coacervate-loaded vascular grafts to common carotid arteries up to 6 months. We will examine early host responses including inflammation and cell infiltration, and correlation between the phenotypes and organization of the recruited cells. We will also investigate the impact of SDF-1? on the rate of endothelialization and ECM production. Successful completion of the proposed research will enhance the aims of the parent R01 and provide an appropriate animal model to address the effect of aging on in situ tissue engineering for arterial regeneration.

Public Health Relevance

Many treatments of cardiovascular disease require bypassing or replacing diseased blood vessels. Despite considerable success with current procedures, polymer-based engineered conduits can enable off-the-shelf availability with sizes and properties better suited for both the pediatric and adult populations. The goal of this project is to design a vascular graft with active cell homing signals that can be transformed into a native artery- like tissue in situ and test the graft in an aged animal model.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL089658-09S1
Application #
9103669
Study Section
Special Emphasis Panel (ZHL1-CSR-P (F1))
Program Officer
Lundberg, Martha
Project Start
2007-07-25
Project End
2017-07-31
Budget Start
2016-09-06
Budget End
2017-07-31
Support Year
9
Fiscal Year
2016
Total Cost
$173,135
Indirect Cost
$60,710
Name
University of Pittsburgh
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lee, Soo Hyon; Lee, Kee-Won; Gade, Piyusha S et al. (2018) Microwave-assisted facile fabrication of porous poly (glycerol sebacate) scaffolds. J Biomater Sci Polym Ed 29:907-916
Ding, Xiaochu; Wu, Yen-Lin; Gao, Jin et al. (2017) Tyramine functionalization of poly(glycerol sebacate) increases the elasticity of the polymer. J Mater Chem B 5:6097-6109
Procter, Nathan Ek; Ball, Jocasta; Ngo, Doan Tm et al. (2016) Gender and tachycardia: independent modulation of platelet reactivity in patients with atrial fibrillation. J Geriatr Cardiol 13:202-8
Khosravi, Ramak; Best, Cameron A; Allen, Robert A et al. (2016) Long-Term Functional Efficacy of a Novel Electrospun Poly(Glycerol Sebacate)-Based Arterial Graft in Mice. Ann Biomed Eng 44:2402-16
Johnson, Noah R; Wang, Yadong (2015) Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds. Wound Repair Regen 23:591-600
Jeffries, Eric M; Allen, Robert A; Gao, Jin et al. (2015) Highly elastic and suturable electrospun poly(glycerol sebacate) fibrous scaffolds. Acta Biomater 18:30-9
Jeffries, Eric M; Nakamura, Shintaro; Lee, Kee-Won et al. (2014) Micropatterning electrospun scaffolds to create intrinsic vascular networks. Macromol Biosci 14:1514-20
Bae, Hojae; Chu, Hunghao; Edalat, Faramarz et al. (2014) Development of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications. J Tissue Eng Regen Med 8:1-14
Allen, Robert A; Wu, Wei; Yao, Mingyi et al. (2014) Nerve regeneration and elastin formation within poly(glycerol sebacate)-based synthetic arterial grafts one-year post-implantation in a rat model. Biomaterials 35:165-73
Johnson, Noah R; Wang, Yadong (2014) Coacervate delivery systems for proteins and small molecule drugs. Expert Opin Drug Deliv 11:1829-32

Showing the most recent 10 out of 28 publications